article · International Journal of HIV/AIDS Prevention Education and Behavioural Science
<i>Background and aim:</i> Neurocognitive disorders are described in people living with HIV (PLWH) on therapeutic anti-retroviral (TARVs), but their determinants are not known. The aim of this study is to determine the determinants of neurocognitive disorders in PLHIV on TARVs. <i>Methods:</i> 45 PLWH on ARVs were analyzed in a cross-sectional study conducted in 2 ARV distribution centers in Kinshasa from August to October 2020. Sociodemographic variables, perceived stress score and neurocognitive disorders were the parameters of interest. A logistic regression made it possible to identify the determinants. The threshold of statistical significance was p <0.05. <i>Results:</i> We recorded 45 patients who met our inclusion criteria. The female sex was the majority (71.1%), the mean age was (50.6 plus or minus 9.1 years) with a sex ratio 3F: 1H, asymptomatic neurocognitive disorders (AND) was more noted in our patients and they was more in the attention and calculation component (60%). All of our patients were under stress, 58% of whom were under high stress; there has been a clear correlation between stress and AND, age> 60 years [aOR: 4.09, 95% CI: 1.63), p = 0.022), unmarried status [aOR: 4.40, 95% CI: 1.79-6.63), p = 0.017) and high perceived stress [aOR: 4.97, 95% CI: 2.72-9.85, p = 0.008) were independent risk factors associated with cognitive impairment in the population of study. <i>Conclusion:</i> The prevalence of neurocognitive disorders was high in PLWH on TARVs and these disorders concerned adults, educated, living alone with a predominance of women. Their determinants were age> 60, loneliness and high stress level.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.11648/j.ijhpebs.20210702.12
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.